Superales, Junrel P.

HRN: 16-41-60  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/17/2023
CEFUROXIME 1.5GM (VIAL)
04/17/2023
04/23/2023
IV
1.5grams
Q8hours
Femoral Fracture
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Bone & Joint    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: